HDL-C inhibits atherosclerosis by removing cholesterol from the vascular wall through reverse cholesterol transport, while apoA1, as the primary structural protein of HDL, shares a similar mechanism in reducing the risk of atherosclerosis. The gene discussed is APOA1; the disease is atherosclerosis.